Rappta Therapeutics
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $11M
Investors
- 4
About Rappta Therapeutics
Founded in 2019 and based in Helsinki, Finland, Rappta Therapeutics Oy operates as a biopharmaceutical company that develops protein phosphatase 2A (PP2A), an anti-cancer drug used to reactivate the key tumor suppressor.
Who invested in Rappta Therapeutics
4 investors across 1 round
See all investors in Rappta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 13, 2020
Amount
$11M
Investors
Questions about Rappta Therapeutics
Who invested in Rappta Therapeutics?
Rappta Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rappta Therapeutics raised?
Rappta Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rappta Therapeutics last raise money?
Rappta Therapeutics's most recent round on record is a Series A, in Oct 2020.
What does Rappta Therapeutics do?
Founded in 2019 and based in Helsinki, Finland, Rappta Therapeutics Oy operates as a biopharmaceutical company that develops protein phosphatase 2A (PP2A), an anti-cancer drug used to reactivate the key tumor suppressor.
Where is Rappta Therapeutics headquartered?
Rappta Therapeutics is headquartered in Helsinki, Finland.
Which VCs invest in companies like Rappta Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Rappta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rappta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.